Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Raisbeck Insider Profile
4 Followers
David Raisbeck, Director at Eastman Chemical, holds 29.36K shares in Eastman Chemical (Ticker: EMN), holds 17.07K shares in Cardinal Health (Ticker: CAH). Most recently, David Raisbeck Sold ― shares of Eastman Chemical on May 15, 2024 for an estimated value of 1.36M.
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+1.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Raisbeck holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Raisbeck
David Raisbeck's Trading History
Eastman Chemical
May 15, 2024
Director
Informative Sell
1.36M
$2.94M
Cardinal Health
Nov 03, 2011
Director
Uninformative Buy
―
$1.63M
List of latest transactions for each holding click on a transaction to see David Raisbeck's performance on stock
You May Also Like
David Raisbeck insider profile FAQ
What is the percentage of profitable transactions made by David Raisbeck?
The percentage of profitable transactions made by David Raisbeck is 67%.
What is the average return per transaction made by David Raisbeck?
The average return per transaction made by David Raisbeck is 1.40%.
What stocks does David Raisbeck hold?
David Raisbeck holds: EMN, CAH stocks.
What was David Raisbeck’s latest transaction?
David Raisbeck latest transaction was an Informative Sell of $1.36M.
What was David Raisbeck's most profitable transaction?
David Raisbeck’s most profitable transaction was an Informative Sell of EMN stock on February 23, 2018. The return on the trade was 28.50%.
What is David Raisbeck's role in Eastman Chemical?
David Raisbeck's role in Eastman Chemical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.